Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Cognitive Functioning and Psychological Well-being in Breast Cancer Patients on Endocrine Therapy.

Biro E, Kahan Z, Kalman J, Rusz O, Pakaski M, Irinyi T, Kelemen G, Dudás R, Drotos G, Hamvai C.

In Vivo. 2019 Jul-Aug;33(4):1381-1392. doi: 10.21873/invivo.11615.

2.

Influence of mutagenic versus non-mutagenic pre-operative chemotherapy on the immune infiltration of residual breast cancer.

Tőkés AM, Rusz O, Cserni G, Tóth E, Rubovszky G, Tőkés T, Vízkeleti L, Reiniger L, Kószó R, Kahán Z, Kulka J, Donia M, Vörös A, Szallasi Z.

Acta Oncol. 2019 Jul 4:1-9. doi: 10.1080/0284186X.2019.1633015. [Epub ahead of print]

PMID:
31271119
3.

Corrigendum to: Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors.

Diossy M, Reiniger L, Sztupinszki Z, Krzystanek M, Timms KM, Neff C, Solimeno C, Pruss D, Eklund AC, Tóth E, Kiss O, Rusz O, Cserni G, Zombori T, Székely B, Kulka J, Tímár J, Csabai I, Szallasi Z.

Ann Oncol. 2019 Mar 30. pii: mdz081. doi: 10.1093/annonc/mdz081. [Epub ahead of print] No abstract available.

4.

Clinical benefit of fulvestrant monotherapy in the multimodal treatment of hormone receptor and HER2 positive advanced breast cancer: a case series.

Rusz O, Kószó R, Dobi Á, Csenki M, Valicsek E, Nikolényi A, Uhercsák G, Cserháti A, Kahán Z.

Onco Targets Ther. 2018 Sep 4;11:5459-5463. doi: 10.2147/OTT.S170736. eCollection 2018.

5.

Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors.

Diossy M, Reiniger L, Sztupinszki Z, Krzystanek M, Timms KM, Neff C, Solimeno C, Pruss D, Eklund AC, Tóth E, Kiss O, Rusz O, Cserni G, Zombori T, Székely B, Tímár J, Csabai I, Szallasi Z.

Ann Oncol. 2018 Sep 1;29(9):1948-1954. doi: 10.1093/annonc/mdy216. Erratum in: Ann Oncol. 2019 Mar 30;:.

6.

LAPTM4B gene copy number gain is associated with inferior response to anthracycline-based chemotherapy in hormone receptor negative breast carcinomas.

Rusz O, Papp O, Vízkeleti L, Molnár BÁ, Bende KC, Lotz G, Ács B, Kahán Z, Székely T, Báthori Á, Szundi C, Kulka J, Szállási Z, Tőkés AM.

Cancer Chemother Pharmacol. 2018 Jul;82(1):139-147. doi: 10.1007/s00280-018-3602-z. Epub 2018 May 16.

PMID:
29770955
7.

The Expression of Checkpoint and DNA Repair Genes in Head and Neck Cancer as Possible Predictive Factors.

Rusz O, Pál M, Szilágyi É, Rovó L, Varga Z, Tomisa B, Fábián G, Kovács L, Nagy O, Mózes P, Reisz Z, Tiszlavicz L, Deák P, Kahán Z.

Pathol Oncol Res. 2017 Apr;23(2):253-264. doi: 10.1007/s12253-016-0088-z. Epub 2016 Jul 13.

PMID:
27411922
8.

[Role of 18FDG-PET/CT in the management and gross tumor volume definition for radiotherapy of head and neck cancer; single institution experiences based on long-term follow-up].

Hideghéty K, Cserháti A, Besenyi Z, Zag L, Gaál S, Együd Z, Mózes P, Szántó E, Csenki M, Rusz O, Varga Z, Dobi Á, Maráz A, Pávics L, Lengyel Z.

Magy Onkol. 2015 Jun;59(2):103-10. Epub 2015 Mar 11. Hungarian.

9.

One-Year Neoadjuvant Endocrine Therapy in Breast Cancer.

Rusz O, Vörös A, Varga Z, Kelemen G, Uhercsák G, Nikolényi A, Ormándi K, Simonka Z, Kahán Z.

Pathol Oncol Res. 2015 Sep;21(4):977-84. doi: 10.1007/s12253-015-9911-1. Epub 2015 Mar 10.

PMID:
25753983
10.

Different methods of pretreatment Ki-67 labeling index evaluation in core biopsies of breast cancer patients treated with neoadjuvant chemotherapy and their relation to response to therapy.

Vörös A, Csörgő E, Kővári B, Lázár P, Kelemen G, Rusz O, Nyári T, Cserni G.

Pathol Oncol Res. 2015 Jan;21(1):147-55. doi: 10.1007/s12253-014-9800-z. Epub 2014 May 25.

PMID:
24859973
11.

Differential immunostaining of various types of breast carcinomas for growth hormone-releasing hormone receptor - Apocrine epithelium and carcinomas emerging as uniformly positive.

Kővári B, Rusz O, Schally AV, Kahán Z, Cserni G.

APMIS. 2014 Sep;122(9):824-31. doi: 10.1111/apm.12224. Epub 2014 Jan 31.

PMID:
24479854
12.

Bone homeostasis and breast cancer: implications for complex therapy and the maintenance of bone integrity.

Rusz O, Kahán Z.

Pathol Oncol Res. 2013 Jan;19(1):1-10. doi: 10.1007/s12253-012-9586-9. Epub 2012 Dec 5. Review.

PMID:
23212591

Supplemental Content

Support Center